1 Swerdlow SH, "WHO Classification of tumours of haematopoietic and lymphoid tissues" IARC Press 2008
2 Tefferi A, "Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact" 28 : 1568-1570, 2014
3 Barbui T, "Rethinking the diagnostic criteria of polycythemia vera" 28 : 1191-1195, 2014
4 Rumi E, "JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes" 123 : 1544-1551, 2014
5 Barbui T, "Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients" 89 : 588-590, 2014
6 Tefferi A, "An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms" 28 : 1407-1413, 2014